These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 98390

  • 1. Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery.
    Gurll N, Zinner MJ, Turtinen L, Reynolds DG.
    Gastroenterology; 1978 Sep; 75(3):425-31. PubMed ID: 98390
    [Abstract] [Full Text] [Related]

  • 2. Vasodilation due to urokinase in the canine femoral circulation.
    Gurll NJ, Zinner MJ, Callahan W, Reynolds DG.
    J Pharmacol Exp Ther; 1977 Jun; 201(3):731-7. PubMed ID: 864605
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 4. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
    Van de Werf F, Jang IK, Collen D.
    J Cardiovasc Pharmacol; 1987 Jan 30; 9(1):91-3. PubMed ID: 2434801
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits.
    Hisano S, Sueishi K, Ishii Y, Tanaka K.
    Thromb Haemost; 1979 Jun 30; 41(4):796-803. PubMed ID: 483251
    [Abstract] [Full Text] [Related]

  • 6. [Intra-arterial infusion with urokinase for embolism of the superior mesenteric artery].
    Ramírez P, Felices JM, Sánchez Bueno F, Luján J, Leal R, Pellicer E, Robles R, Parrilla P.
    Rev Esp Enferm Dig; 1990 Jun 30; 77(6):441-3. PubMed ID: 2223254
    [Abstract] [Full Text] [Related]

  • 7. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Jun 30; (3):51-4. PubMed ID: 6342687
    [Abstract] [Full Text] [Related]

  • 8. High-dose, short-term local urokinase for clearing femoral thrombi by vasodilation and thrombolysis.
    Gurll NJ, Callahan W, Hufnagel HV.
    J Surg Res; 1976 May 30; 20(5):381-8. PubMed ID: 933494
    [No Abstract] [Full Text] [Related]

  • 9. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
    Maksimenko AV.
    Bioorg Khim; 1998 May 30; 24(5):376-80. PubMed ID: 9661792
    [Abstract] [Full Text] [Related]

  • 10. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F.
    Arzneimittelforschung; 1988 Mar 30; 38(3A):474-8. PubMed ID: 3134901
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D, Stassen JM, De Cock F.
    Thromb Haemost; 1987 Oct 28; 58(3):943-6. PubMed ID: 3124288
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
    Rupin A, Martin F, Vallez MO, Bonhomme E, Verbeuren TJ.
    Thromb Haemost; 2001 Dec 28; 86(6):1528-31. PubMed ID: 11776323
    [Abstract] [Full Text] [Related]

  • 13. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
    Bode C, Runge M, Eberle T, Freitag M, Kübler W, Haber E.
    Trans Assoc Am Physicians; 1989 Dec 28; 102():7-12. PubMed ID: 2517856
    [No Abstract] [Full Text] [Related]

  • 14. [Infusion therapy for acute superior mesenteric artery occlusion].
    Hatanaka Y, Takada C, Torashima M, Yamashita Y, Korogi M, Takahashi M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May 25; 53(5):520-5. PubMed ID: 8327316
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the vascular action of dopamine in the canine mesenteric bed.
    Dóbi I, Kékesi V.
    Acta Chir Hung; 1989 May 25; 30(4):251-60. PubMed ID: 2561778
    [Abstract] [Full Text] [Related]

  • 16. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM, Juhan-Vague I, Alessi MC, De Cock F, Collen D.
    Thromb Haemost; 1987 Oct 28; 58(3):947-50. PubMed ID: 2829381
    [Abstract] [Full Text] [Related]

  • 17. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S, Astrup T.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract] [Full Text] [Related]

  • 18. An artificial circulation for the study of thrombolysis. The influence of flow rate and pressure on thrombolysis and a comparison between urokinase and tissue activator as thrombolytic agents.
    Walker JE, Flook V, Ogston D.
    Acta Haematol; 1983 Dec 31; 69(1):41-6. PubMed ID: 6401892
    [Abstract] [Full Text] [Related]

  • 19. Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.
    Collen D, Stump D, van de Werf F, Jang IK, Nobuhara M, Lijnen HR.
    Circulation; 1985 Aug 31; 72(2):384-8. PubMed ID: 3924437
    [Abstract] [Full Text] [Related]

  • 20. [Local thrombolysis in peripheral arterial occlusion].
    Hess H.
    Herz; 1989 Feb 31; 14(1):12-21. PubMed ID: 2522076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.